🇺🇸 FDA
Patent

US 8980258

Bispecific single chain Fv antibody molecules and methods of use therof

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 8980258 (Bispecific single chain Fv antibody molecules and methods of use therof) held by The Regents of the University of California expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61K39/395, A61K51/109, A61P